Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)
Category: Media Release
Statement from Microbio Ltd Board
23 May 2023 For Immediate Release Statement From Microbio Microbio chair Mary Harney today announced the appointment of a new interim CEO following the decision of founding CEO and shareholder Paul Carboon to step away from the role. Harney said that Colin Keating would assume the role on an interim basis while the search for… Continue reading Statement from Microbio Ltd Board
Microbio closes latest investment round after surpassing $3.5m target
Queensland biotechnology scale-up Microbio has closed its latest investment round after surpassing its $3.5 million target. This investment will facilitate Microbio expanding regulatory approval into international markets, having already received clearance for distribution and use in Europe and the UK, with approval in India and South America expected by the end of 2022, and TGA… Continue reading Microbio closes latest investment round after surpassing $3.5m target
ISO certification opens new markets for Microbio
Brisbane based biotech scale-up, Microbio, is set to take on new local and international markets after gaining International Organisations for Standardisation (ISO) 13485:2016 Certification for its quality management system. Read more in the media release: 221115 ISO Certification opens new markets for Microbio
Microbio conducts commercial evaluation trials in Ecuador
Australian biotech scale-up Microbio has started commercial evaluation trials in Ecuador prior to launching its flagship InfectID-BSI (Bloodstream Infection) test in South America. Read more in the media release: 221019 Microbio conducts commercial evaluation trials in Ecuador